Bio Essence Statistics
Total Valuation
Bio Essence has a market cap or net worth of 3.61 million. The enterprise value is 6.35 million.
| Market Cap | 3.61M |
| Enterprise Value | 6.35M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Essence has 38.01 million shares outstanding. The number of shares has increased by 7.97% in one year.
| Current Share Class | 38.01M |
| Shares Outstanding | 38.01M |
| Shares Change (YoY) | +7.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 90.49% |
| Owned by Institutions (%) | n/a |
| Float | 3.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.43 |
| PB Ratio | -1.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 4.69 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.85 |
| EV / Sales | 18.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -238.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.46% |
| Return on Invested Capital (ROIC) | -43.51% |
| Return on Capital Employed (ROCE) | 17.85% |
| Revenue Per Employee | 173,065 |
| Profits Per Employee | -824,244 |
| Employee Count | 2 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bio Essence has paid 800 in taxes.
| Income Tax | 800 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.11% in the last 52 weeks. The beta is 11.69, so Bio Essence's price volatility has been higher than the market average.
| Beta (5Y) | 11.69 |
| 52-Week Price Change | -83.11% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 8.17 |
| Average Volume (20 Days) | 1,320 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, Bio Essence had revenue of 346,129 and -1.65 million in losses. Loss per share was -0.04.
| Revenue | 346,129 |
| Gross Profit | 237,665 |
| Operating Income | -512,702 |
| Pretax Income | -1.65M |
| Net Income | -1.65M |
| EBITDA | -511,994 |
| EBIT | -512,702 |
| Loss Per Share | -0.04 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 2.74M |
| Net Cash | -2.74M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -3.17M |
| Book Value Per Share | -0.08 |
| Working Capital | -2.87M |
Cash Flow
| Operating Cash Flow | 769,409 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 68.66% |
| Operating Margin | -148.12% |
| Pretax Margin | -476.03% |
| Profit Margin | n/a |
| EBITDA Margin | -147.92% |
| EBIT Margin | -148.12% |
| FCF Margin | n/a |
Dividends & Yields
Bio Essence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.97% |
| Shareholder Yield | n/a |
| Earnings Yield | -45.65% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio Essence has an Altman Z-Score of -46.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.35 |
| Piotroski F-Score | 3 |